BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32124308)

  • 1. Bioinformatics for Cancer Immunotherapy.
    Holtsträter C; Schrörs B; Bukur T; Löwer M
    Methods Mol Biol; 2020; 2120():1-9. PubMed ID: 32124308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery.
    de Sousa E; Lérias JR; Beltran A; Paraschoudi G; Condeço C; Kamiki J; António PA; Figueiredo N; Carvalho C; Castillo-Martin M; Wang Z; Ligeiro D; Rao M; Maeurer M
    Front Immunol; 2021; 12():592031. PubMed ID: 34335558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
    Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
    J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in personalized neoantigen vaccines for cancer immunotherapy.
    Sun C; Xu S
    Biosci Trends; 2020 Nov; 14(5):349-353. PubMed ID: 32908077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Methods for Identification of T Cell Neoepitopes in Tumors.
    Jurtz VI; Olsen LR
    Methods Mol Biol; 2019; 1878():157-172. PubMed ID: 30378075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized vaccines for cancer immunotherapy.
    Sahin U; Türeci Ö
    Science; 2018 Mar; 359(6382):1355-1360. PubMed ID: 29567706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoepitopes as cancer immunotherapy targets: key challenges and opportunities.
    Brennick CA; George MM; Corwin WL; Srivastava PK; Ebrahimi-Nik H
    Immunotherapy; 2017 Mar; 9(4):361-371. PubMed ID: 28303769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants for Neoantigen Identification.
    Garcia-Garijo A; Fajardo CA; Gros A
    Front Immunol; 2019; 10():1392. PubMed ID: 31293573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
    Aldous AR; Dong JZ
    Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods behind neoantigen prediction for personalized anticancer vaccines.
    Godazandeh K; Van Olmen L; Van Oudenhove L; Lefever S; Bogaert C; Fant B
    Methods Cell Biol; 2024; 183():161-186. PubMed ID: 38548411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best practices for bioinformatic characterization of neoantigens for clinical utility.
    Richters MM; Xia H; Campbell KM; Gillanders WE; Griffith OL; Griffith M
    Genome Med; 2019 Aug; 11(1):56. PubMed ID: 31462330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neoepitope landscape of breast cancer: implications for immunotherapy.
    Narang P; Chen M; Sharma AA; Anderson KS; Wilson MA
    BMC Cancer; 2019 Mar; 19(1):200. PubMed ID: 30832597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens.
    Pan RY; Chung WH; Chu MT; Chen SJ; Chen HC; Zheng L; Hung SI
    J Immunol Res; 2018; 2018():4325874. PubMed ID: 30662919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Next-Generation Sequencing in Neoantigen Prediction and Cancer Vaccine Development.
    Lancaster EM; Jablons D; Kratz JR
    Genet Test Mol Biomarkers; 2020 Feb; 24(2):59-66. PubMed ID: 30907630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The present status and future prospects of peptide-based cancer vaccines.
    Hirayama M; Nishimura Y
    Int Immunol; 2016 Jul; 28(7):319-28. PubMed ID: 27235694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoantigen vaccine: an emerging tumor immunotherapy.
    Peng M; Mo Y; Wang Y; Wu P; Zhang Y; Xiong F; Guo C; Wu X; Li Y; Li X; Li G; Xiong W; Zeng Z
    Mol Cancer; 2019 Aug; 18(1):128. PubMed ID: 31443694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines.
    Türeci Ö; Vormehr M; Diken M; Kreiter S; Huber C; Sahin U
    Clin Cancer Res; 2016 Apr; 22(8):1885-96. PubMed ID: 27084742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next generation approaches for tumor vaccination.
    Patel A; Kaufman HL; Disis ML
    Chin Clin Oncol; 2017 Apr; 6(2):19. PubMed ID: 28482672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GeNeo: A Bioinformatics Toolbox for Genomics-Guided Neoepitope Prediction.
    Al Seesi S; Al-Okaily A; Shcheglova TV; Sherafat E; Alqahtani FH; Hagymasi AT; Kaur A; Srivastava PK; Măndoiu II
    J Comput Biol; 2023 Apr; 30(4):538-551. PubMed ID: 36999902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations.
    Toor JS; Rao AA; McShan AC; Yarmarkovich M; Nerli S; Yamaguchi K; Madejska AA; Nguyen S; Tripathi S; Maris JM; Salama SR; Haussler D; Sgourakis NG
    Front Immunol; 2018; 9():99. PubMed ID: 29441070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.